Multiple anticancer activities of EF24, a novel curcumin analog, on human ovarian carcinoma cells

Reproductive Sciences

Volumn 17, Issue 10, 2010, Pages 931-940

  Tan, Xin ^a,b   Sidell, Neil ^b   Mancini, Alessandra ^c   Huang, Ruo Pan ^b   Shenming Wang, ^a   Horowitz, Ira R ^b   Liotta, Dennis C ^c   Taylor, Robert N ^b   Wieser, Friedrich ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

angiogenesis; antioxidants; apoptosis; curcumin; ovarian cancer; VEGF

Indexed keywords

ANTINEOPLASTIC AGENT; CURCUMIN; EF 24; HYDROGEN PEROXIDE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; TERT BUTYLHYDROQUINONE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; DRUG MECHANISM; DRUG STRUCTURE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; UPREGULATION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZYLIDENE COMPOUNDS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; OVARIAN NEOPLASMS; PIPERIDONES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77957156555     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719110374239     Document Type: Article

References (37)

1. Chobanian N., Dietrich CS 3rd. Ovarian cancer. Surg Clin North Am. 2008 ; 88 (2). 285-299, vi.
2. Sharma RA, Euden SA, Platton SL, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res. 2004 ; 10 (20). 6847-6854.
3. Dhillon N., Aggarwal BB, Newman RA, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008 ; 14 (14). 4491-4499.
4. Anand P., Kunnumakkara AB, Newman RA, Aggarwal BB Bioavailability of curcumin: problems and promises. Mol Pharm. 2007 ; 4 (6). 807-818.
5. Adams BK, Ferstl EM, Davis MC, et al. Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents. Bioorg Med Chem. 2004 ; 12 (14). 3871-3883.
6. Adams BK, Cai J., Armstrong J., et al. EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism. Anticancer Drugs. 2005 ; 16 (3). 263-275.
7. Subramaniam D., May R., Sureban SM, et al. Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity. Cancer Res. 2008 ; 68 (6). 1962-1969.
8. Selvendiran K., Tong L., Vishwanath S., et al. EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression. J Biol Chem. 2007 ; 282 (39). 28609-28618. (Pubitemid 47606012)
9. Spannuth WA, Sood AK, Coleman RL Angiogenesis as a strategic target for ovarian cancer therapy. Nat Clin Pract Oncol. 2008 ; 5 (4). 194-204.
10. Paley PJ, Staskus KA, Gebhard K., et al. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer. 1997 ; 80 (1). 98-106.
11. Yamamoto S., Konishi I., Mandai M., et al. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. Br J Cancer. 1997 ; 76 (9). 1221-1227.
12. Duncan TJ, Al- Attar A., Rolland P., et al. Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies ? Clin Cancer Res. 2008 ; 14 (10). 3030-3035.
13. Lin YG, Kunnumakkara AB, Nair A., et al. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Cancer Res. 2007 ; 13 (11). 3423-3430.
14. Ruby AJ, Kuttan G., Babu KD, Rajasekharan KN, Kuttan R. Antitumour and antioxidant activity of natural curcuminoids. Cancer Lett. 1995 ; 94 (1). 79-83.
15. Bengmark S. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J Parenter Enteral Nutr. 2006 ; 30 (1). 45-51.
16. Dinkova-Kostova AT, Massiah MA, Bozak RE, Hicks RJ, Talalay P. Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc Natl Acad Sci USA. 2001 ; 98 (6). 3404-3409.
17. Nguyen T., Yang CS, Pickett CB The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic Biol Med. 2004 ; 37 (4). 433-441.
18. Xia C., Meng Q., Liu LZ, Rojanasakul Y., Wang XR, Jiang BH Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res. 2007 ; 67 (22). 10823-10830.
19. Roy S., Khanna S., Sen CK Redox regulation of the VEGF signaling path and tissue vascularization: hydrogen peroxide, the common link between physical exercise and cutaneous wound healing. Free Radic Biol Med. 2008 ; 44 (2). 180-192.
20. Boatright KM, Salvesen GS Mechanisms of caspase activation. Curr Opin Cell Biol. 2003 ; 15 (6). 725-731.
21. Sidell N., Feng Y., Hao L., et al. Retinoic acid is a cofactor for translational regulation of vascular endothelial growth factor in human endometrial stromal cells. Mol Endocrinol. 2010 ; 24 (1). 148-160.
22. Feliers D., Gorin Y., Ghosh-Choudhury G., Abboud HE, Kasinath BS Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species. Am J Physiol Renal Physiol. 2006 ; 290 (4). F927 - F936.
23. Balogun E., Hoque M., Gong P., et al. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J. 2003 ; 371 (pt 3). 887-895.
24. Dinkova-Kostova AT, Talalay P. Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res. 2008 ; 52 (suppl 1). S128 - S138.
25. Prochaska HJ, Talalay P. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res. 1988 ; 48 (17). 4776-4782.
26. Rushmore TH, Morton MR, Pickett CB The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem. 1991 ; 266 (18). 11632-11639.
27. Drisko JA, Chapman J., Hunter VJ The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer. J Am Coll Nutr. 2003 ; 22 (2). 118-123.
28. Duvoix A., Blasius R., Delhalle S., et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 2005 ; 223 (2). 181-190.
29. Zhang L., Yang N., Park JW, et al. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res. 2003 ; 63 (12). 3403-3412.
30. Rudlowski C., Pickart AK, Fuhljahn C., et al. Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up. Int J Gynecol Cancer. 2006 ; 16 (suppl 1). 183-189.
31. Yoysungnoen P., Wirachwong P., Bhattarakosol P., Niimi H., Patumraj S. Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice. Clin Hemorheol Microcirc. 2006 ; 34 (1-2). 109-115.
32. Sun A., Shoji M., Lu YJ, Liotta DC, Snyder JP Synthesis of EF24-tripeptide chloromethyl ketone: a novel curcumin-related anticancer drug delivery system. J Med Chem. 2006 ; 49 (11). 3153-3158.
33. Shoji M., Sun A., Kisiel W., et al. Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa. J Drug Target. 2008 ; 16 (3). 185-197.
34. Dulak J., Loboda A., Jozkowicz A. Effect of heme oxygenase-1 on vascular function and disease. Curr Opin Lipidol. 2008 ; 19 (5). 505-512.
35. Cho M., Hunt TK, Hussain MZ Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release. Am J Physiol Heart Circ Physiol. 2001 ; 280 (5). H2357 - H2363.
36. Masuda T., Maekawa T., Hidaka K., Bando H., Takeda Y., Yamaguchi H. Chemical studies on antioxidant mechanism of curcumin: analysis of oxidative coupling products from curcumin and linoleate. J Agric Food Chem. 2001 ; 49 (5). 2539-2547.
37. Piper JT, Singhal SS, Salameh MS, Torman RT, Awasthi YC, Awasthi S. Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver. Int J Biochem Cell Biol. 1998 ; 30 (4). 445-456.